Greener Journal of Medical Sciences

Vol. 14(2), pp. 42-48, 2024

ISSN: 2276-7797

Copyright ©2024, the copyright of this article is retained by the author(s)

https://gjournals.org/GJMS

 

 

 

 

Click on Play button... 

 

 

Effect of Calabash Chalk on the Liver Enzymes, Blood Glucose Level and Clotting Time of Female Wistar Rats

 

 

Uchefuna, Roy Chinwuba1; Abba, Chike Chizurum1; Ezeokafor, Emmanuel Nonso1; Ifemenam, Kosisochukwu Emmanuel2; Ebisintei, Precious3; Nwaefulu, Kester Eluemunor1; Okonkwo, Raymond Maduabuchi4;Dim Catherine Nicholate5; Ezeh Anthonia Kanayo6

 

 

 

1 Department of Human Physiology, Nnamdi Azikiwe University, Nnewi Campus.

2 Department of Obstetrics and Gynecology, Chukwuemeka Odumegwu Ojukwu University Teaching Hospital, Awka.

3 Department of Biological Sciences, University of Africa Toru-Orua, Health Science

4 Faculty of Pharmaceutical Sciences, Department of Pharmacology, Enugu State University of Sciences and Technology.

5 Department of Human Physiology, Chukwuemeka Odumegwu Ojukwu University, Uli.  

6 Department of Obstetrics and Gynecology, Abia State University Teaching Hospital, Aba.

 

 

ARTICLE INFO

ABSTRACT

 

Article No.: 050924058

Type: Research

Full Text: PDF, PHP, HTML. EPUB, MP3

Calabash chalk is a natural geophagic mineral composed mainly of fossilized seashells or an artificial preparation of a combination of clay, mud, and sand. It is one of the widely consumed earth materials in the practice of geophagia. Calabash chalk which contains some heavy metals is generally taken by women and children, with pregnant and postpartum women craving more for it to subsidize nausea and other early morning sicknesses. This study takes into account some impacts of the Calabash chalk to the liver, blood glucose level and clotting time. For the study, 25 female wistar rats were used and they were assigned into five (5) groups (A-E) of 5 rats each and housed in five standard cages. Group A served as Positive control (received just feed and water) Group B, C, D and E received 200, 400, 800 and 1600mg/kg of the Calabash chalk extract respectively. The result revealed that calabash chalk caused a significant decrease on the AST (Aspartate aminotransferase) level of group C which was administered 400mg/kg and ALP (Alkaline phosphatase) level of group E which was administered 1600mg/kg while there was a significant increase in the ALT (Alanine transaminase) level of group D and E which were administered 800 and 1600mg/kg respectively, and the liver weight of group D which was administered 800mg/kg decreased significantly. It had no significant increase on the blood glucose levels of group C, D and E which were administered 400, 800 and 1600mg/kg respectively, but caused a significant increase on group B which was administered 200mg/kg. The calabash chalk had no significant effect on the clotting time of all the experimental groups.

 

Accepted:  13/05/2024

Published: 03/06/2024

 

*Corresponding Author

Ifemenam, Kosisochukwu Emmanuel

E-mail: kossylinkz@ gmail.com

 

Keywords: Calabash Chalk, AST, ALT, ALP, Clotting Time

 

 

 


INTRODUCTION

 

1.1 Background of Study

 

Calabash chalk is a naturally geophagic mineral composed mainly of fossilized seashells or an artificial preparation of a combination of clay, mud, and sand. It is one of the widely consumed earth materials in the practice of geophagia. (Akpantah et al., 2010).

Calabash chalk geophagy, a common practice in Nigeria and some other sub-Saharan African countries, is also practiced in developed countries. The chalk which is a mixture of clay and chalk is mostly consumed by women and children, with pregnant and postpartum women craving more for it due to their emotional states; usually attributed to feelings of misery, homesickness, depression and alienation. (Akpantah et al., 2010).

Calabash chalk is also known as calabash clay, Calabar stones, poto, la craie or argile in French, nzu in Igbo and ndom in Efiks/Ibibios of Nigeria, and mabele in Lingala of Congo. It is naturally occurring, but there are artificially formulated forms as well (Akpantah et al., 2010). . The naturally occurring forms is chiefly made up of fossilized seashells, while the artificial forms may be prepared from clay and mud, which may be mixed with other ingredients including sand, wood ash and sometimes salt. The resulting product is molded and then heated to produce the final product (Abrahams et al., 2006).

Calabash chalk is generally made up of aluminum silicate hydroxide, a member of the kaolin clay group, with the formula: Al2 Si2 O5 OH4. It also contains several other substances which could be poisonous to the body depending on their bioavailability. These include; metals, metalloids and persistent organic pollutants (Abrahams et al., 2006).

In most African countries, Calabash chalk or Calabash clay is one of the most common geophagic materials. Popularly called Nzu in Nigeria, Calabash chalk is known as La Craie or Argile in French, and Mabele in Congo. It is found and obtained usually from the soil (mining pits), and occurs naturally as a light brown to almost white solid which is relatively soluble in water. Calabash chalk is marketed in the raw form or processed by combining clay, sand, wood ash or salt; packaged as powder, molded blocks or pellets and is readily available in open shops. It is consumed by many because it is believed to have various ethno botanical uses. It is used as antacid, antidiarrheal, contraceptive, nutritional supplement, wound healing, and skin beautification agent. (Ekong et al., 2010). It is also used for the treatment of skin diseases, fetal growth and wellbeing during pregnancy,] and sociocultural activities. In general, pregnant women gravitate more toward Calabash chalk consumption in humans. They use Calabash chalk as remedy for morning sickness and to satisfy their increased appetite and other peculiar desires. (Akpantah et al., 2010).

 

 

METHODOLOGY

 

The study was carried out in the department of Physiology, Nnamdi Azikiwe University in the faculty of Basic Medical Science; the rats were housed in cages of the animal house of the College of Health Science, Nnamdi Azikiwe University, Nnewi campus. Ethical approval was obtained from the Faculty of Basic Medical science ethical committee, Faculty of Basic Medical Science, College of Health Science, Nnamdi Azikiwe University, Nnewi campus. Rats handling and treatments conform to the rodent handling and restraint (J0VE science education) manual.

The study lasted for five (5) weeks which included: two (2) weeks of acclimatization of the Wister rats and three (3) weeks of extract administration during which the animals’ weight was checked and recorded.

Twenty (25) young female rats of the Wister strain weighing between 110-140g were used for the study. They were allowed to acclimatize for period of fourteen (14) days. The experimental animals were assigned into five (5) groups (A-E) of 4 rats each and housed in five standard cages.

Group A served as Positive control (received just feed and water), Group B received 200mg/kg of the Calabash chalk extract, Group C received 400mg/kg of the Calabash chalk extract, Group D received 800mg/kg of the Calabash chalk extract, and Group E received 1600mg/kg of the Calabash chalk extract.

The experiment lasted for 21 days, after which the animals were anesthetized using chloroform in an enclosed container for two minutes and blood samples collected via ocular puncture as described by Parasuraman et al. (2017) after which liver enzymes, clotting time and blood glucose levels where determined.

 

 

RESULT

 

Table 1 revealed a significant increase in the body weight in groups A, B, C, and D while group E had a non-significant increase when the initial weight was compared to the final weight.


 

 

 

Table 1: Effect of Calabar Chalk on the weight of Rats

 

Initial weight (g)

Final weight (g)

P-value

T-value

 

MEAN±SEM

  MEAN±SEM

 

 

Group A (control)

117.79±9.23

171.52±9.23

0.005*

-3.087

Group B (200 mg/kg of Calabash chalk)

122.84±4.75

159.20±8.02

0.048*

-3.238

Group C (400 mg/kg of Calabash chalk)

116.31±4.63

162.40±6.60

0.003*

-9.228

Group D (800 mg/kg of Calabash chalk)

130.73±4.37

166.55±5.71

0.028*

-4.016

Group E (1600 mg/kg of Calabash chalk)

126.59±10.05

156.06±12.70

0.248a

-1.614

 

 


Table 2 revealed a non-significant increase in groups C, D, and E (p=0.402, p=0.230, p=0.306) while group B (p=0.002) had a significant increase compared to group A.

 

The clotting time result demonstrated a non-significant increase in groups B and C (p=0.667, p=0.885) while groups D and E (p=0.352, p=0.395) had a non-significant decrease compared to group A.


 

Table 2: Effect of Calabar Chalk on the Glucose level and Clotting Time of Rats

 

Glucose level (mg/dl)

Clotting time (seconds)

 

MEAN±SEM

  MEAN±SEM

Group A (control)

90.33±2.72

50.00±12.58

Group B (200 mg/kg of Calabash chalk)

111.660±2.02*

55.00±5.77 a

Group C (400 mg/kg of Calabash chalk)

94.66±1.45a

51.66±9.27 a

Group D (800 mg/kg of Calabash chalk)

96.66±3.28a

39.00±5.56 a

Group E (1600 mg/kg of Calabash chalk)

95.66±6.06a

40.00±2.88 a

F-value

5.38

0.82

 

 

 


Table 3 result revealed a non-significant decrease in AST level in groups B and E (p=0.319, 0.119), group D (p=0.848) indicated a non-significant increase and group C (p=0.040) showed a significant decrease compared to group A.

The ALT result reported a non-significant increase in-group B (p=0.803) and group C (p=0.709) had a non-significant increase, and groups D and E (p=0.018, p=0.005) had a significant increase compared to group A.

The ALP result demonstrated a non-significant decrease in groups B and D (p=0.418, p=192), group C (p=0.054) had a non-significant increase and group E (p=0.001) had a significant decrease compared to group A.

The relative liver weight showed a non-significant decrease in groups B, C, and E (p=0.729, p=0.897, p=0.310) and group D (p=0.021) had a significant decrease compared to group A.


 

 

Table 3: Effect of Calabar Chalk on Liver Enzymes (AST, ALT, ALP) and Organ Weight.

 

 

Aspartate Transaminase (IU/L)

Alanine Transaminase (IU/L)

Alkaline Phosphatase (IU/L)

relative liver weight (g)

 

MEAN±SEM

  MEAN±SEM

MEAN±SEM

MEAN±SEM

Group A (control)

46.33±10.26

23.66±2.30

439.06±100.83

3.87±0.46

Group B (200 mg/kg of Calabash chalk)

41.00±4.00a

24.33±0.57a

393.83±91.42a

3.75±0.05 a

Group C (400 mg/kg of Calabash chalk)

34.33±0.57*

22.66±1.52a

555.96±42.32a

3.82±0.27 a

Group D (800 mg/kg of Calabash chalk)

47.33±8.02 a

31.00±5.19*

364.16±28.61a

2.97±0.07*

Group E (1600 mg/kg of Calabash chalk)

37.66±2.88a

33.00±4.00*

89.78±19.76*

3.52±0.05a

F-value

2.38

6.54

20.63

2.55

 

 

 


DISCUSSION

 

There are limited works on the impact of Calabash chalk on the liver, blood glucose and clotting time.

The mean body weight change of the rats in Groups A B, C and D (Table 1) were significantly (P<0.05) high. This result is in variance with the study carried out by (Chinko et al., 2022) which reported a reduction in weight amongst the experimental animals when compared to the control. It is possible that the doses administered were not enough to effect such changes. Studies by Akpantah et al., 2010 and Moses et al., 2012 showed that abrasive quartz content in calabash chalk interfered with their normal nutrient absorption which may have played a role in appetite suppression and reduction of lipid profile (Alli and Nafiu, 2017) which was evident in group E where increase in weight was not statistically significant. 

There was no significant increase in blood glucose levels of groups C, D, and E While there was a significant increase in group B compared to the control group A. The result suggests that the arsenic content of the Calabash chalk may have caused the significant increase on the glucose level in group B as a study done by Ana et al, 2005 showed that Arsenic could influence diabetes development.

There was no significant effect of the calabash on the clotting time across all groups. Which suggest that calabash chalk had no effect on the clotting time. However, no studies have been done to support this claim and hence further research id recommended.

There was a significant decrease in the AST levels of group C when compared to the control group. A study done by Mauro and Diana et al, showed that AST levels are expected and that however, low AST may be due to Vitamin B6 deficiency in rare cases.

There was significant increase in the ALT levels of group D and E when compared with the control group. This may suggest some degree of hepatic damage with increasing doses of calabash chalk.

There was a significant decrease in ALP level in Group E which may be due to inactivation of the enzyme molecules by the active components in the calabash chalk.

There was a significant decrease in the weight of the liver of Group D when compared with the control group. A decrease in organ weight may reflect loss of function mass associated with atrophy (Giboney et al., 2005). A study by Ekong et al, 2008 and Nafiu et al, 2016 reported that some of the liver enzymes of wista rats were significantly affected following administration of calabash chalk.

The study showed that calabash chalk had no adverse effects on the clotting time and body weight but it may however cause significant damage to the liver and cause an increase in the blood glucose level when administered for a long period. Further studies are however recommended.

 

 

Ethical Approval

 

Ethical approval was obtained from the Ethical Committee of Nnamdi Azikwe University, Nnewi Campus.

 

 

REFERENCES

 

1.         Abrahams P.W, Davies T.C, Solomon A.O, Trow A.J, Wragg A., (2013). Human geophagia, calabash chalk and undongo: mineral element nutritional implications. National Library of Sciences. 8(1), pp.53-62.

2.         Akah, P.A., Zeigbo, T.O., Oforkansi, M.N. and Onyeto, C.A., (2020). Effect of kaolin consumption on serum heavy metal levels of pregnant women. International Journal of Sciences, 9(04), pp.28-32.

3.         Akpantah A.O, Ibok O.S, Ekong M.B, Eluwa M.A, Ekanem T.B., (2010). The effect of calabash chalk on some haematological parameters in female adult Wistar rats. Turk Journal of Hematol. 2(85), pp.177-181.

4.         Ana N.A, Ellen K.S, Robin A.S, Jeane M.C, Thomas A.C., (2005). Arsenic exposure and Type 2 diabetes: A systematic and epidemiological review. Environmental Health perspect. 27(3), pp. 85-98.

5.         Bancroft J.D, Gamble M. London G.B: Churchill L., (2007). Theory and practice of histological techniques. Journal of medicine. 75(8), pp.356-368.

6.         Berg J.M, Tymoczko J.L, Stryer L., (2006). Biochemistry of Liver enzymes. Biochemistry. 4(21), pp. 656–660.

7.         Bressler J., Kim K.A, Chakraborti T., Goldstein G., (2006). Molecular mechanisms of lead neurotoxicity. Neurochemistry Research. 24(4), pp.595–600.

8.         Brewer D.B, Max S., (2006). "The discovery of the platelet". British Journal of Haematology. 133 (3), pp.8-21.

9.         Biswas, A., (2019). "Structure functional insights into calcium binding during the activation of coagulation factor XIII A". Scientific Reports journal. 9 (1), pp.11-31.

10.      Campbell H., Belfast I.E., (2002). Calabash chalk (Calabar stone, la craie, nzu). Journal of Social Service and Public Safety. 6(82), pp.72-86.

11.      Canfield R.L, Henderson C.R, Cory-Slechta D.A, Cox C., Jusko T.A, Lanphear B.P., (2003). Intellectual impairment in children with blood lead concentrations below 10 μg per deciliter. England Journal of Medicine. 348(16) pp.1517–1526.

12.      Chinkol T.H, Ebana G.E, Abrahams R.H (2017). The effect of calabash chalk on the histomorphology of wistar rats. Journal of Research. 87(6), pp.65-78.

13.      Daghlas S.A, Mohiuddin S.S., (2022). Biochemistry of Glycogen. StatPearls journal. 3(89), pp.76-87.

14.      David L., Nigel K., Michael M., Denise O., (2009). Practical Hemostasis and Thrombosis. Wiley-Blackwell journals. 8(25), pp. 7–16.

15.      Dean J.R, Deary M.E, Gbefa B.K, Scott W.C., (2004). Characterisation and analysis of persistent organic pollutants and major, minor and trace elements in Calabash chalk. Chemosphere. 57(1), pp.21–25.

16.      Dooley E.E., (2010). The dangers of calabash chalk.  Environmental Health Perspect. 2 (18), pp.200–209.

17.      Dubelldam K.W, Kaplowitz N., (2008). Transaminase activity in human blood. Journal of medical investigation. 8(71), pp.871-895.

18.      Dufour D.R, Lott J.A, Nolte F.S, Gretch D.R, Koff R.S, Seeff L.B., (2000). "Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests". Clinical Chemistry. 46(12), pp.27–49.

19.      Dutt M, Wehrle C.J, Jialal I., (2022). Physiology, Adrenal Gland. International medical journal. 4(23), pp.87-99.

20.      Ebana P.W., (2019). “Earth eaters”: ancient and modern perspectives on human geophagy. Soil and culture. 7(32), pp.369-398.

21.      Ekong M.B, Peter A.I, Ekanem T.B, Osim E.E., (2015). Determination of elemental composition and median lethal dose of calabash chalk. Journal of Basic Applied Resources International.5(2), pp.83–89.

22.      El Sayed S.A, Mukherjee S., (2022). Physiology, Pancreas. StatPearls Journal. 9(6), pp.87-97.

23.      Frumkin H, Thun M.J., (2001). Arsenic. CA Cancer Journal. 51(4), pp.254–262.

24.      Furie M, Barbara C.L, Bruce F., (2005). "Thrombus formation in vivo". The Journal of Clinical Investigation. 115(12), pp.55–62.

25.      Gaze D.C., (2007). "The role of existing and novel cardiac biomarkers for cardioprotection". Journal of Current Opinion in Investigational Drugs. 8 (9), pp.711–717.

26.      Ghouri N, Preiss D.H, Sattar N., (2010). "Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data". Hepatology. 52 (3), pp.56–61.

27.      Giannini E.H, Testa R.T, Savarino V., (2005). "Liver enzyme alteration: a guide for clinicians". Canadian Medical Association Journal. 172 (3), pp.67–79.

28.      Giboney P.T., (2005). "Mildly elevated liver transaminase levels in the asymptomatic patient". American Family Physician. 71(6), pp.5–10.

29.      Goyal R.J, Jialal I., (2022). StatPearls. Diabetes Mellitus Type 2. StatPearl journal. 6(89), pp.45-72.

30.      Goyer R.A., (2004). Transplacental transport of lead. Environmental Health Perspect. 6(89), pp.101–105.

31.      Hayashi H.J, Mizuguchi H.K, Miyahara I, Nakajima Y.J, Hirotsu K, Kagamiyama H., (2003). "Conformational change in aspartate aminotransferase on substrate binding induces strain in the catalytic group and enhances catalysis". The Journal of Biological Chemistry. 278 (11), pp.9481–9488.

32.      Hirotsu K.D, Goto M, Okamoto A, Miyahara I., (2005). "Dual substrate recognition of aminotransferases". Chemical Record. 5 (3), pp.160–172.

33.      Hoffbrand A.V, Pettit, J.E Moss, P. A. H. (2002). Essential Haematology. Blackwell Science journal. 8(56), pp. 241–243.

34.      Hoekstra L.T, de Graaf W, Nibourg G.A, Heger M.E, Bennink R.J, Stieger B, van Gulik TM., (2013). Physiological and biochemical basis of clinical liver function tests. Journal of Medicine. 257(1), pp.27-36.

35.      Hoffman, M.R, (2003). "Remodeling the blood coagulation cascade". Journal of Thrombosis and Thrombolysis. 16(2), pp.17–20.

36.      Holesh J.E, Aslam S, Martin A., (2022). Physiology, Carbohydrates. StatPearls Journal. 6(89), pp.671-682.

37.      Huber J.S, Stanworth S.J, Doree C, Fortin P.M, Trivella M, Brunskill S.J., (2019). "Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures". The Cochrane Database of Systematic Reviews. 5(11), pp.86-98.

38.      Hughes J.N, Wickramasinghe S.N, Hatton N, Chris J., (2008). Haematology. Wiley-Blackwell journal. 7(35), pp. 145-166.

39.      Kandel E.R, Schwartz J.H, Jessell T.M., (2000). Principles of neural science. Journal of medicine. 2(7), p.63-79.

40.      Kiernan J.A. Philadelphia P.A., (2009). Barr’s the human nervous system: an anatomical viewpoint. Journal of Human system. 9(27), pp.87-96.

41.      Kumar V.F, Abbas A.K, Fausto N. Philadelphia (PA)., (2005). Pathologic basis of disease. New clinical journal. 6(21), pp.98-106.

42.      Lala V.H, Goyal A, Bansal P, Minter D., (2020). "Liver Function Tests". StatPearls journal. 78(5), pp.86-95).

43.      Lillicrap D.K, Nigel K, Makris M.D, Shaughnessy O., (2009). Practical Hemostasis and Thrombosis. Wiley-Blackwell journals. 9(78), pp.1-5.

44.      Lockless S.W, Zhou M, MacKinnon R., (2007). Structural and thermodynamic properties of selective ion binding in a K+ channel. PLoS Biol. 5(5), pp.121-128.

45.      Long A.T, Kenne E, Jung R, Fuchs T.A, Renné T.,(2016). "Contact system revisited: an interface between inflammation, coagulation, and innate immunity". Journal of Thrombosis and Haemostasis. 14 (3), pp.86-95.

46.      Marshall W.S., (2012). "Alanine aminotransferase: analyte monograph"(PDF). Association for Clinical Biochemistry and Laboratory Medicine. 9(76), pp. 3–7.

47.      Michelson D.G, Alan D., (2006). Platelets. Elsevier. 8(98), pp.3–5.

48.      Navale A.M, Paranjape A.N., (2016). Glucose transporters: physiological and pathological roles. Journal of Biophysiology. 8(1), pp.5-9.

49.      Nawale R.B, Mourya V.K, Bhise S.B., (2006). Non-enzymatic glycation of proteins: a cause for complications in diabetes. Indian Journal of Biochem Biophys.43(6), pp.37-44.

50.      Nigel K.I, Michael M., (2009). Practical Hemostasis and Thrombosis. Wiley-Blackwell journals. 9(78), pp.26-40.

51.      Ontario C.N., (2007). Calabash chalk may pose risk to pregnant women. Health Canada. 8(20), pp.66-75.

52.      Osaki T.H, Hirotsu M., (2004). "Structure and function of coagulogen, a clottable protein in horseshoe crabs". Cellular and Molecular Life Sciences. 61 (11), pp.57–65.

53.      Pallister C.J, Watson M.S., (2010). Haematology. Scion journal. 9(85), pp. 336–347.

54.      Palta A.H, Palta S., Saroa R., (2014). "Overview of the coagulation system". Indian Journal of Anaesthesia. 58 (5), p.p.515–523.

55.      Pirahanchi Y, Tariq M.A, Jialal I., (2023). Physiology, Thyroid. StatPearl journal. 8(56), pp.65-82.

56.      Ramachandran S., Groves J.A, Xia G.L, Saá P, Notari E.P, Drobeniuc J, Poe A, Khudyakov N, Schillie S.F, Murphy T.V, Kamili S, Teo C.G, Dodd R.Y, Khudyakov Y.E, Stramer S.L., (2019). Recent and occult hepatitis B virus infections among blood donors in the United States. Medical journal. 9(2), pp.601-611.

57.      Rawindraraj A.D, Basit H, Jialal I., (2022).  Physiology, Anterior Pituitary. StatPearl journal. 5(21), pp.65-83.

58.      Rouche M.G, chade C.E, Wakselman S, Poncer J.C, Real E., (2008). Prenatal activation of microglia induces delayed impairment of glutamatergic synaptic function. PLoS Biol. 3(7), pp.86-95.

59.      Sadler T.W, Delhi I.N: Wolters K., (2010). Development of femur. Langman’s medical embryology. 35(67), pp.98-105.

60.      Schmaier G.D, Alvin H., Lazarus F.R,, Hillard M., (2011). Concise guide to hematology. Wiley-Blackwell journals. 6(82), pp.86-91.

61.      Shapiro M.A., (2003). "Treating thrombosis in the 21st century". The New England Journal of Medicine. 349 (18), pp.2-4.

62.      Signorelli G.A, Salvatore S.M; Oliveri Conti G, Fiore M, Maria C, Cangiano F.S, Zuccarello M., (2020). "Platelet-Derived Microparticles (MPs) and Thrombin Generation Velocity in Deep Vein Thrombosis (DVT): Results of a Case–Control Study". Vascular Health and Risk Management. 16(2),pp.489–495.

63.      Singh, S.G, Dodt J.A, Volkers P.J, Hethershaw, E.K, Philippou H, Ivaskevicius V.F, Imhof D.; Oldenburg J.; Clotting Mechanism. Journal of medicine. 2(67), pp.89-96.

64.      Soff G.A., (2012). "A new generation of oral direct anticoagulants". Arteriosclerosis, Thrombosis, and Vascular Biology. 32 (3), pp.69–74.

65.      Su W, Mao Z.H, Liu Y.W, Zhang X, Zhang W, Gustafsson J.A, Guan Y., (2019). Role of HSD17B13 in the liver physiology and pathophysiology. Moelcular Cell Endocrinology. 1(489), pp.119-125.

66.      Vahter M.A., (2009). Effects of arsenic on maternal and fetal health. Journal of Revisional Nutrition. (4)29, pp.381–399.

67.      Van O.D., (2005). "Red Cross Donor Requirements". American Red Cross of Tompkins County. American medical journal. 8(67), pp.65-78.

68.      Vargas E C, Joy N.V, Sepulveda M.A., (2022). Biochemistry, Insulin Metabolic Effects. International medical journal. 2(81), pp.231-245.

69.      Venugopal S.K, Sankar P, Jialal I., (2023). Physiology, Glucagon. International medical Journal. 8(75), pp.98-112.

70.      Watkins P.B, Kaplowitz N, Slattery J.T, Colonese C.R, Colucci S.V, Stewart P.W, Harris S.C., (2006). "Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial". Medical journal. 296(1), pp.87–93.

71.      Watson M.S.; Pallister C.J., (2010). Haematology. Scion Journal. 6(72), pp.334–336.

72.      Zadorozhnaja T.D, Little R.E, Miller R.K, Mendel N.A, Taylor R.J, Presley B.J., (2000). Concentrations of arsenic, cadmium, copper, lead, mercury, and zinc in human placentas from two cities in Ukraine. Toxicology Environmental Health. 61(4), pp.255–263.

 


 

 

Cite this Article: Uchefuna, RC; Abba, CC; Ezeokafor, EN; Ifemenam, KE; Ebisintei, P; Nwaefulu, KE; Okonkwo, RM; Dim, CN; Ezeh, AK (2024). Effect of Calabash Chalk on the Liver Enzymes, Blood Glucose Level and Clotting Time of Female Wistar Rats. Greener Journal of Medical Sciences, 14(2): 42-48.